Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 6, 2024.

Balance Sheet: Liabilities and Stockholders’ Equity

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Shockwave Medical Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in thousands

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Accounts payable
Debt, current portion
Employee compensation
Asset purchases
Professional services
Research and development costs
Excise, sales, income and other taxes
Sales and marketing
Other
Accrued liabilities
Operating lease liability, current portion
Current liabilities
Operating lease liability, noncurrent portion
Convertible debt, noncurrent portion
Debt, noncurrent portion
Related party contract liability, noncurrent portion
Deferred tax liabilities
Long-term income tax liability
Other liabilities
Noncurrent liabilities
Total liabilities
Preferred stock, $0.001 par value per share; no shares issued and outstanding
Common stock, $0.001 par value per share
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings (accumulated deficit)
Stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Liabilities Overview
There is a marked increase in total liabilities over the period, rising from $39.3 million in 2019 to $897.9 million in 2023. This substantial growth is primarily driven by a significant escalation in noncurrent liabilities, which surged from $15.3 million in 2019 to $793.7 million in 2023. Current liabilities also increased, almost quadrupling from $24.0 million in 2019 to $104.2 million in 2023.
Current Liabilities Details
Accounts payable exhibited fluctuations with a decrease in 2020 followed by continuous growth to $8.9 million in 2023. Accrued liabilities showed a strong upward trend, increasing over fivefold to nearly $91.7 million by 2023. Current operating lease liabilities varied over time but ended higher in 2023 at $3.6 million compared to $0.8 million in 2019. Debt in its current portion declined by 2022 and was not reported thereafter.
Noncurrent Liabilities Details
Noncurrent debt showed variability, rising until 2022 but falling off by 2023 with no reported values. Notably, convertible debt surged dramatically to $731.9 million in 2023, becoming the dominant component of noncurrent liabilities. Related party contract liabilities remained stable at approximately $12.3 million from 2021 onward. Other noncurrent liabilities appeared for the first time in 2023 with an amount of $9.3 million.
Equity and Capital Structure
Common stock showed marginal increase from $31,000 to $37,000 over the period. Additional paid-in capital consistently rose, from $370.6 million in 2019 to $557.9 million in 2023, reflecting capital injections or stock issuance. Retained earnings moved from negative $178.0 million in 2019 to a positive $110.5 million by 2023, indicating a recovery in accumulated profitability or equity retention. Accumulated other comprehensive income fluctuated but turned positive in 2023 to $0.3 million. Overall stockholders' equity more than tripled, reaching $668.7 million in 2023.
Income and Expense Trends
Employee compensation expenses increased markedly, rising from $8.1 million in 2019 to $49.7 million in 2023, signifying expansion in workforce or compensation levels. Professional services costs also rose steadily, nearly eightfold, to $6.3 million by 2023. Research and development outlays showed variability but doubled from $3.1 million in 2019 to $8.1 million in 2023. Sales and marketing expenses appeared in the data from 2022 onward, increasing from $2.0 million to $3.5 million in 2023. Taxes (excise, sales, income, and other) increased drastically from $1.2 million in 2021 to $12.3 million in 2023, suggesting increased revenue or taxable events.
Asset Investment
Asset purchases were recorded starting in 2020 and showed a clear upward trend, reaching $7.8 million in 2023, indicative of investment in fixed or capital assets over the period.
Financial Position Summary
Total assets and liabilities plus equity grew considerably from 2019 ($232.0 million) to 2023 ($1.57 billion), indicating substantial organizational growth or financing events. The rise in liabilities, especially convertible debt, suggests increased leverage or complex financing arrangements to support growth initiatives. Improved retained earnings and increased equity reflect strengthening financial health despite rising liabilities. The growth in operational expenses, including employee costs and professional services, aligns with expansion activities.